F2-isoprostanes and Metabolite, and Breast Cancer Risk
N Am J Med Sci (Boston)
.
2009 Jul;2(3):106-108.
doi: 10.7156/v2i3p106.
Authors
Qi Dai
1
,
Xiangzhu Zhu
Affiliation
1
Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, School of Medicine, Vanderbilt University, Nashville, TN.
PMID:
20648235
PMCID:
PMC2905829
DOI:
10.7156/v2i3p106
No abstract available
Grants and funding
R01 CA106591/CA/NCI NIH HHS/United States
R01 CA106591-01/CA/NCI NIH HHS/United States